Clinical Trial Update: Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients

View source ↗

Summary

This clinical trial update discusses how the concurrent use of steroids with immune-checkpoint inhibitors may influence survival outcomes in patients with non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Seoul National University | Conditions: NSCLC, Non Small Cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING